Drugmakers Metsera and Maze Raise Combined $415 Million in IPOs
A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...
FierceBiotech8d
Maze rolls out map to $131M IPO, as phase 2 kidney disease trial readies for dosing
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...
Maze Therapeutics IPO opens trading modestly higher
Maze Therapeutics, a clinical-stage biopharmaceutical company, launched its initial public offering (IPO) today, with shares ...
Science Daily13h
Researchers solve a fluid mechanics mystery
Seven years ago, researchers caught an unexpected phenomenon on film: A pool of red dye that somehow 'knew' how to solve a maze filled with milk. Propelled forward by a couple drops of soap, it ...
Seeking Alpha4d
Maze Therapeutics stock hugs flat line following $140M IPO
Maze Therapeutics (NASDAQ:MAZE) shares were trading largely flat following a $140M initial public offering. Shares of the kidney disease drug developer opened at $16 per share after being priced ...
Turtle Bay Tuesday: Mission Aerospace is set to launch at Turtle Bay Exploration Park
In this week's Turtle Bay Tuesday, the Exploration Park's Mission Aerospace exhibit invites visitors to embark on an ...